Cormorant Asset Management
VC
2014
$4 000 M
Palo Alto, California, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Cormorant Asset Management is a venture capital, hedge fund, and investment vehicle. The firm was founded in Boston, Massachusetts, United States.
The firm is interested in asset management, finance, and financial services and offers their services in the Greater Boston Area, and New England area of the United States. The firm has made a total of seventy five investments in companies that include FORMA Therapeutics for over $100 million, and has had over forty exits. The firm has a child hub called Cormorant Asset Management Portfolio Companies.
Cormorant Asset Management is a Boston-based investment manager with investment focus in both public and private market innovative companies in the biotechnology and life sciences marketplace.
Cormorant Asset Management, LLC operates as an investment management company. The Company provides portfolio management and advisory services to pooled investment vehicles. Cormorant Asset Management serves clients worldwide.
Industry
Region of investment
Cormorant Asset Management Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Early Stage Fund
|
Venture Capital (VC)
|
Biotechnology
Life Sciences
|
Pre-seed
Seed
Series A
|
North America
|
$5-10 m
|
$250 M
|
December 2019
|
|
Diversify Capital Fund (DCF)
|
Venture Capital (VC)
|
Biotechnology
Life Sciences
|
Pre-seed
Seed
Series A
|
North America
|
$5-10 m
|
$300 M
|
September 2021
|
|
Long Term View (LTV) Fund
|
Venture Capital (VC)
|
Biotechnology
Life Sciences
|
Pre-seed
Seed
Series A
|
North America
|
$5-10 m
|
$380 M
|
September 2021
|
|
Early Stage Fund II
|
Venture Capital (VC)
|
Biotechnology
Life Sciences
|
Pre-seed
Seed
Series A
|
North America
|
$5-10 m
|
$700 M
|
October 2024
|
